Centiva Capital »

Lyell Immunopharma shares owned by Centiva Capital

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Centiva Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $31k 22k 1.38
2023-09-30 $29k 20k 1.47

More positions owned by Centiva Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Ishares Tr 7-10 Yr Trsy Bd Put Option (IEF)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr National Mun Etf (MUB)
Agnc Invt Corp Com reit (AGNC)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Boeing Company Call Option (BA)
Meta Platforms Cl A (META)
Advanced Micro Devices (AMD)
Ishares Tr Russell 2000 Etf (IWM)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Centiva Capital

Top funds holding Lyell Immunopharma

MWG Management
Orland Properties
BlackRock
BlackRock
Vanguard Group
Foresite Capital Management IV
WuXi AppTec
T. Rowe Price Associates
OrbiMed Advisors
Alphabet
Geode Capital Management
State Street Corporation
Sc China Holding
MIC Capital Management UK
Opaleye Management

View all funds holding Lyell Immunopharma